![Kari Nadeau](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kari Nadeau
Keine laufenden Positionen mehr
Profil
Kari Nadeau is the founder of IgGenix, Inc. which was founded in 2019.
Ehemalige bekannte Positionen von Kari Nadeau
Unternehmen | Position | Ende |
---|---|---|
IgGenix, Inc.
![]() IgGenix, Inc. BiotechnologyHealth Technology IgGenix, Inc. operates as a biotechnology company. It isolates and transforms allergen-specific IgE antibodies into IgG antibodies that are designed to alleviate and possibly prevent the allergic cascade. The company was founded by Stephen D. Quake, Kari Nadeau, Derek Croote, and Bruce Hironaka in 2019 and is headquartered in South San Francisco, CA. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
IgGenix, Inc.
![]() IgGenix, Inc. BiotechnologyHealth Technology IgGenix, Inc. operates as a biotechnology company. It isolates and transforms allergen-specific IgE antibodies into IgG antibodies that are designed to alleviate and possibly prevent the allergic cascade. The company was founded by Stephen D. Quake, Kari Nadeau, Derek Croote, and Bruce Hironaka in 2019 and is headquartered in South San Francisco, CA. | Health Technology |